Once-weekly diabetes drug backed in draft NICE guidance

Once-weekly type-2 diabetes drug exenatide has been recommended for third-line use in draft guidance from NICE.

NICE draft guidance recommends exenatide
NICE draft guidance recommends exenatide

Exenatide prolonged release has been recommended for use with metformin in addition to either a sulphonylurea or a thiazolidinedione. Its use should be restricted to people HbA1c levels above 7.5% and a BMI over 35 or who are unsuitable for insulin therapy, NICE has said.

The draft recommends that long-acting exenatide should only be used for patients unsuitable for triple therapy with any three of: metformin, a sulphonylurea, a thiazolidinedione and a dipeptidyl peptidase-4 inhibitor.

NICE’s draft guidance on long-acting exenatide is open for consultation until 8 November, with final guidance likely to be published in February 2012.

Commenting on the draft decision, Professor Carole Longson, director of the health technology evaluation centre at NICE said: ‘Type-2 diabetes is becoming increasingly more common in adults, so we are pleased to recommend exenatide as a treatment option for some people with the condition.’

Long-acting exenatide is marketed by Eli Lilly as Bydureon suspension for injection.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Close up of hand holding sample tube with 'Omicron' handwritten on side

Government urged to 'free up' GP practices and expand steps to control Omicron

GPs have called for immediate action such as suspension of QOF to allow practices...

(Photo: Mike Kemp/Getty Images)

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

External wall of GP surgery with wording 'medical centre'

‘Utterly toxic’: GPs speak out over abuse and physical attacks on practice teams

GPs have condemned a rise in verbal and physical attacks on practice staff - warning...

Artist's image of a spiked virus

Javid warns of 'substantial risk' from new COVID-19 variant

The highly mutated COVID-19 variant B.1.1.529 'may pose a significant risk to public...

Desk with lettering 'LMC conference'

LMCs reject 'outdated' GMS contract and demand move to item of service payments

LMCs have voted to scrap the 'outdated and inadequate' GMS contract and to replace...

GPs at an LMC conference waving green voting cards in the air

LMCs demand ringfence on enhanced services cash and clear GP representation in ICSs

LMCs have called for a ringfence on enhanced services funding, along with a guarantee...